Psychotherapy with Hallucinogenic Adjuncts from a Learning Perspective

References

• Aaronson B., Osmond H. Psychedelics–The Uses and Implications of Hallucinogenic Drugs. Anchor, Garden City, New York 1970
   Google Scholar
• The Use of LSD in Psychotherapy and Alcoholism., H. Abramson. Bobbs-Merrill, New York 1967
   Google Scholar
• Appel J. B. Effects of LSD on time-based schedules of reinforcement. Psychopharmacologia 1971; 21: 174–186
   PubMedGoogle Scholar
• Asher J. Whatever happened to psychedelic research?. Am. Psychol. Assoc. Monitor November, 1975; 4–5
   Google Scholar
• Baker E. F.W. LSD psychotherapy: LSD psycho-exploration. The Use of LSD in Psychotherapy and Alcoholism., H. A. Abramson. Bobbs-Merrill, New York 1967
   Google Scholar
• Becker D. I., Appel J. B., Freedman D. X. Some effects of lysergic acid diethylamide on visual discrimination in pigeons. Psychopharmacologia 1967; 11: 354–364
   PubMedGoogle Scholar
• Bignami C. Facilitation of avoidance acquisition by Lsd-25. Psychopharmacologia 1972; 25: 146–151
   PubMedGoogle Scholar
• Blough D. S. Some effects of drugs on visual discrimination in the pigeon. Ann. N.Y. Acad. Sci. 1957; 66: 733–739
   PubMed Web of Science ®Google Scholar
• Bonny H. L., Pahnke W. N. The use of music in psychedelic (LSD) therapy. J. Music Ther. 1972; 9: 64–87
   Google Scholar
• Bowen W. E., Soskin R. A., Chotlos J. W. Lysergic acid diethylamide as a variable in the hospital treatment of alcoholism. J. Nerv. Ment. Dis. 1970; 150: 111–118
   PubMedGoogle Scholar
• Bridger W. H., Mandel I. J. Excitatory and inhibitory effects of mescaline on shuttle avoidance in the rat. Biol. Psychol. 1971; 3: 379–385
   Google Scholar
• Bridger W. H., Mandel I. J., Stoff D. N. Mescaline: No tolerance to excitatory effects. Biol. Psychol. 1973; 7: 129–138
   Google Scholar
• Buckman J. Theoretical aspects of LSD therapy. The Use of LSD in Psychotherapy and Alcoholism., H. A. Abramson. Bobbs-Merrill, New York 1967
   Google Scholar
• Buckman J. Psychedelic drugs as adjuncts to analytic psychotherapy. Psychedelic Drugs, R. E. Hicks, et al. Grune & Stratton, New York 1969
   Google Scholar
• Busch A. K., Johnson W. C. LSD as an aid in psychotherapy. Dis. Nerv. Syst. 1950; 11: 241–243
   PubMedGoogle Scholar
• Bylinsky G. Mood Control. Scribner, New York 1978
   Google Scholar
• Calder J. Apparent Results of Referrals of Alcoholics for LSD Therapy. Bureau on Alcoholism, ReginaCanada 1962
   Google Scholar
• Chandler A. L., Hartman M. A. LSD-25 as a facilitating agent in psychotherapy. Arch. Gen. Psychiatry 1960; 2: 286–299
   Web of Science ®Google Scholar
• Cheek F. E., Osmond H., Sarett M., Albahary R. S. Observations regarding the use of LSD-25 in the treatment of alcoholism. J. Psychopharmacol. 1966; 1: 56–74
   Google Scholar
• Chwelos N., Blewett D. B., Smith C. M., Hoffer A. Use of d-lysergic acid diethylamide in the treatment of alcoholism. Q. J. Stud. Alcohol 1959; 20: 577–590
   PubMedGoogle Scholar
• Cleckner P. J. Hallucinogens in the United States: A diagnostic evaluation. J. Psychedelic Drugs 1977; 9: 133–141
   Web of Science ®Google Scholar
• Cohen S. Psychotherapy with LSD: Pro and con. The Use of LSD in Psychotherapy and Alcoholism., H. A. Abramson. Bobbs-Merrill, New York 1967
   Google Scholar
• Corbett L., Christian S. T., Morin R. D., Benington F., Smythies J. R. Hallucinogenic N-methylated indolealkylamines in the cerebrospinal fluid of psychiatric and control populations. Br. J. Psychiatry 1978; 132: 139–144
   PubMed Web of Science ®Google Scholar
• Davis M., Bear H. D. Effects of N, N-dimethyltryptamine on retention of startle response habituation in the rat. Psychopharmacologia 1972; 27: 29–44
   PubMedGoogle Scholar
• Di Leo F. The use of psychedelics in psychotherapy. J. Alter. States Conscious 1976; 2: 225–337
   Google Scholar
• Ditman K. S., Bailey J. J. Evaluating LSD as a psychotherapeutic agent. The Use of LSD in Psychotherapy and Alcoholism., H. A. Abramson. Bobbs-Merrill, New York 1967
   Google Scholar
• Eisner B. G., Cohen S. Psychotherapy with lysergic acid diethylamide. J. Nerv. Ment. Dis. 1958; 127: 528–539
   PubMed Web of Science ®Google Scholar
• Eysenck H. J. The effects of psychotherapy. Handbook of Abnormal Psychology., H. J. Eysenck. Basic Books, New York 1960
   Google Scholar
• Faillace L. A., Vourlekis A., Szara S. Hallucinogenic drugs in the treatment of alcoholism: A two-year follow-up. Compr. Psychiatry 1970; 11: 51–56
   PubMed Web of Science ®Google Scholar
• Foulds G. Clinical research in psychiatry. J. Ment. Sci. 1958; 104: 259–265
   PubMed Web of Science ®Google Scholar
• Gardner E. L. Effects of LSD-25 on bar pressing behavior in the hooded rat. Psychon. Sci. 1965; 3: 507–508
   Google Scholar
• Glick B., Margolis R. A study of the influence of experimental design on clinical outcome in drug research. Am. J. Psychiatry 1962; 118: 1087–1096
   Web of Science ®Google Scholar
• Goodwin S. E., Mahoney J. J. Modification of aggression through modeling: An experimental probe. J. Behav. Ther. Exp. Psychiatry 1975; 6: 200–202
   Web of Science ®Google Scholar
• Gray P. H. Theory and evidence of imprinting in human infants. J. Psychol. 1958; 46: 155–166
   Web of Science ®Google Scholar
• Grof S. The use of LSD-25 in personality diagnostics and therapy of psychogenic disorders. The Use of LSD in Psychotherapy and Alcoholism., H. A. Abramson. Bobbs-Merrill, New York 1967
   Google Scholar
• Grof S. Realms of the Human Unconscious: Observations from LSD Research. Viking, New York 1975
   Google Scholar
• Grof S., Soskin R. A., Richards W. A., Kurland A. A. DPT as an adjunct in psychotherapy of alcoholics. Int. J. Pharmacopsychiatry 1973; 8: 104–115
   PubMedGoogle Scholar
• Haley T. J. Brain concentrations of LSD-25 (Delysid) after intracerebral or intravenous administration in conscious animals. Experientia 1957; 13: 199–200
   PubMedGoogle Scholar
• Hoffer A. A program for the treatment of alcoholism: LSD, malvaria, and nicotinic acid. The Use of LSD in Psychotherapy and Alcoholism., H. A. Abramson. Bobbs-Merrill, New York 1967
   Google Scholar
• Hoffer A., Osmond H. The Hallucinogens. Academic, New York 1967
   Google Scholar
• Hollister L. E., Shelton J., Krieger C. A controlled comparison of lysergic acid diethylamide (LSD) and dextroamphetamine in alcoholics. Am. J. Psychiatry 1969; 125: 58–63
   Web of Science ®Google Scholar
• Jensen S. E. A treatment program for alcoholics in a mental hospital. Q. J. Stud. Alcohol 1962; 23: 3–5
   Google Scholar
• Jensen S. E., Ramsey R. Treatment of chronic alcoholism with lysergic acid diethylamide. Can. Psychiatr. Assoc. J. 1963; 8: 182–188
   PubMedGoogle Scholar
• Johnson F. G. LSD in the treatment of alcoholism. Am. J. Psychiatry 1969; 126: 481–487
   PubMed Web of Science ®Google Scholar
• Kahn J., Gorelick D. A., Bridger W. H. Mescaline facilitates retention of passive avoidance in rats. Physiol. Psychol. 1974; 2: 120–122
   Google Scholar
• Kanner L. Childhood Psychosis: Initial Studies and New Insights. Wiley, New York 1973
   Google Scholar
• Kast E. Pain and LSD-25: A theory of attenuation of anticipation. The Consciousness-Expanding Drug, D. LSD Solomon. Putnam, New York 1964
   Google Scholar
• Kast E. LSD and the dying patient. Chicago Med. Sch. Q. 1966; 26: 80–87
   PubMedGoogle Scholar
• Kluver H. Mescal and Mechanisms of Hallucinations. University of Chicago Press, Chicago 1969
   Google Scholar
• Kurland A. A., Savage C., Pahnke W. N., Grof S., Olsson J. E. LSD in the treatment of alcoholics. Pharmakopsychiatr./Neuro-Psycho-Psychopharmakol. 1971; 4: 83–94
   Google Scholar
• Kurland A. A., Unger S., Shaffer J. W., Savage C. Psychedelic therapy utilizing LSD in the treatment of the alcoholic patient: A preliminary report. Am. J. Psychiatry 1967; 123: 1202–1209
   PubMed Web of Science ®Google Scholar
• La Barre W. Primitive psychotherapy in native American cultures: Peyotism and confession. J. Abnorm. Soc. Psychol. 1947; 24: 294–309
   Google Scholar
• Leary T. Neurologic. Level Press, San Francisco 1975
   Google Scholar
• Leary T., Metzner R., Presnell M., Weil C., Schwitzgebel R., Kinne S. A new behavior change program using psilocybin. Psychotherapy 1965; 2: 61–72
   Web of Science ®Google Scholar
• Leuner H. Present state of psycholytic therapy and its possibilities. The Use of LSD in Psychotherapy and Alcoholism., H. A. Abramson. Bobbs-Merrill, New York 1967
   Google Scholar
• Leuner H. Basic functions involved in the psychotherapeutic effect of psychotomimetics. Research in Psychotherapy., J. M. Shlien. American Psychological Association, Washington, D.C. 1968
   Google Scholar
• Levine J., Ludwig A. M. The hypnodelic treatment technique. The Use of LSD in Psychotherapy and Alcoholism., H. A. Abramson. Bobbs-Merrill, New York 1967
   Google Scholar
• Ling T. M. The use of LSD-25 and Ritalin in the treatment of neurosis. The Use of LSD in Psychotherapy and Alcoholism., H. A. Abramson. Bobbs-Merrill, New York 1967
   Google Scholar
• Ludwig A. M., Levine J. A controlled comparison of the five brief treatment techniques employing Lsd, hypnosis, and psychotherapy. Am. J. Psychother. 1965; 19: 417–435
   PubMed Web of Science ®Google Scholar
• Ludwig A. M., Levine J., Stark L. H. LSD and Alcoholism–A Clinical Study of Treatment Efficacy. Thomas, Springfield, Illinois 1970
   Google Scholar
• MacLean J. R., MacDonald D. C., Byrne V. P., Hubbard A. M. The use of LSD in the treatment of alcoholism and other psychiatric problems. Q. J. Stud. Acohol 1961; 22: 34–45
   PubMedGoogle Scholar
• MacLean J. R., MacDonald D. C., Ogden F., Wilby E. LSD and mescaline as therapeutic adjuvants. The Use of LSD In Psychotherapy and Alcoholism., H. A. Abramson. Bobbs-Merrill, New York 1967
   Google Scholar
• Mascher E. Psycholytic therapy: Statistics and indications, Neuro-psycho-pharmacology. Proceedings of the Fifth International Congress of the Collegium Internationale Neuro-psychopharmacologicum, H. Brill, et al. Excerpta Medica Foundation, Amsterdam 1967; 441–444
   Google Scholar
• McCabe O. L. Psychedelic (LSD) psychotherapy: A case report. Psychotherapy 1974; 11: 2–10
   Web of Science ®Google Scholar
• McGlothlin W. H. Social and para-medical aspects of hallucinogenic drugs. The Use of LSD in Psychotherapy and Alcoholism., H. A. Abramson. Bobbs-Merrill, New York 1967
   Google Scholar
• Meehl P. Psychotherapy. Ann. Rev. Psychol. 1955; 6: 357–378
   PubMed Web of Science ®Google Scholar
• Meichenbaum D., Cameron R. The clinical potential of modifying what clients say to themselves. Self-Control: Power to the Person., M. Mahoney, C. Thresen. Brooks/Cole, Monterey, California 1974
   Google Scholar
• Mogar R., Savage C. Personality change associated with psychedelic (LSD) therapy: A preliminary report. Psychotherapy 1964; 1: 154–162
   Web of Science ®Google Scholar
• Moore D. J., Shiek D. A. Toward a theory of early infantile autism. Psychol. Rev. 1971; 78: 451–456
   PubMed Web of Science ®Google Scholar
• Nathan P. E., Biddell D. W. Behavioral assessment and treatment of alcoholism. Treatment and Rehabilitation of the Chronic Alcoholic., B. Kissin, H. Begleiter. Plenum, New York 1977
   Google Scholar
• National Institute of Mental Health. Research in the Service of Mental Health–Report of the Research Task Force of the National Institute of Mental Health. U.S. Government Printing Office, Washington, D.C. 1975
   Google Scholar
• O'Reilly P. O. Brief psychotherapy, LSD and the alcoholic. The Use of LSD in Psychotherapy and Alcoholism., H. A. Abramson. Bobbs-Merrill, New York 1967
   Google Scholar
• O'Reilly P. O., Funk A. LSD in chronic alcoholism. Can. Psychiatr. Assoc. J. 1964; 9: 258–260
   PubMedGoogle Scholar
• Osmond H. A review of the clinical effects of psychotomimetic agents. Ann. N.Y. Acad. Sci. 1957; 66: 418–434
   PubMed Web of Science ®Google Scholar
• Osmond H. June 7, 1978, Personal communication
   Google Scholar
• Pahnke W. N., Kurland A. A., Unger S., Savage C., Grof S. The experimental use of psychedelic (LSD) psychotherapy. J. Am. Med. Assoc. 1970a; 212: 1856–1863
   PubMed Web of Science ®Google Scholar
• Pahnke W., Kurland A., Unger S., Savage C., Wolf S., Goodman L. Psychedelic therapy (utilizing LSD) with terminal cancer patients. J. Psychedelic Drugs 1970b; 3: 63–75
   Web of Science ®Google Scholar
• Pahnke W. N., Richards W. A. Implications of LSD and experimental mysticism. J. Transpers. Psychol. 1969; 1: 69–102
   Google Scholar
• Pollard J. C., Uhr L., Stern E. Drugs and Phantasy–The Effects of LSD, Psilocybin, and Sernyl on College Students. Little, Brown, Boston 1965
   Google Scholar
• Rhead J. C. The use of psychedelic drugs in the treatment of severely disturbed children: A review. J. Psychedelic Drugs 1977; 9: 93–101
   Web of Science ®Google Scholar
• Rhead J. June 13, 1978, Personal Communication
   Google Scholar
• Rhead J. C., Soskin R. A., Turek I., Richards W. A., Yensen R., Kurland A. A., Ota K. Y. Psychedelic drug (DPT)-assisted psychotherapy with alcoholics: A controlled study. J. Psychedelic Drugs 1977; 9: 287–300
   Web of Science ®Google Scholar
• Richards W. A. Archetypal and mystical experiences of terminal patients during psychedelic drug-assisted psychotherapy. Paper presented at the Symposium on Religious Experience and Altered States of Consciousness, Annual Meeting of the American Psychological Association, Washington, D.C., 1976
   Google Scholar
• Richards W., Grof S., Goodman L., Kurland A. LSD-assisted psychotherapy and the human encounter with death. J. Transpers. Psychol. 1972; 4: 121–150
   Google Scholar
• Richards W. A., Rhead J. C., Di Leo F. B., Yensen R., Kurland A. A. The peak experience variable in DPT-assisted psychotherapy with cancer patients. J. Psychedelic Drugs 1977; 9: 1–10
   Web of Science ®Google Scholar
• Rinkel M., De Shon H. J., Hyde R. W., Solomon H. C. Experimental schizophrenia-like symptoms. Am. J. Psychiatry 1952; 108: 572–578
   PubMed Web of Science ®Google Scholar
• Rosen A. J., Buga J. A. Effects of lysergic acid diethylamide on simple instrumental conditioning, extinction, and discrimination learning in the rat. Pharmacol. Biochem. Behav. 1973; 1: 619–627
   PubMedGoogle Scholar
• Rosen A. J., Kubos K. L. Effects of N, N-dimethyltryptamine on intracranial self-stimulation in the rat. Life Sci. 1973; 12: 89–96
   Google Scholar
• Rouse L. O., Frank L. D. Facilitation of learned resistance to audiogenic seizures in Bulb/cCrgl mice by d-LSD-25. Nature 1974; 248: 78–81
   PubMed Web of Science ®Google Scholar
• Salzman A. Controlled therapy research with psychedelic drugs: A critique. Psychedelic Drugs., R. E. Hicks, et al. Grune & Stratton, New York 1969
   Google Scholar
• Savage C. Psychedelic therapy. Res. Psychother. 1968; 3: 512–520
   Google Scholar
• Savage C., McCabe O. L. Residential psychedelic (LSD) therapy of narcotic addiction: A controlled study. Arch. Gen. Psychiatry 1973; 28: 808–814
   PubMed Web of Science ®Google Scholar
• Savage C., McCabe O. L., Kurland A. A., Hanlon T. LSD-assisted psychotherapy in the treatment of severe chronic neurosis. J. Alter. States Conscious 1973; 1: 31–47
   Google Scholar
• Savage C., Terrill J., Jackson D. LSD, transcendence, and the new beginning. J. Nerv. Ment. Dis. 1962; 135: 425–439
   PubMed Web of Science ®Google Scholar
• Shagass C., Bittle R. M. Therapeutic effects of LSD: A follow-up study. J. Nerv. Ment. Dis. 1967; 144: 471–478
   PubMed Web of Science ®Google Scholar
• Shulgin A. T., Carter M. F. Centrally active phenethylamines. Psychopharmacol. Commun. 1975; 1: 93–97
   PubMedGoogle Scholar
• Silverman J. On the effects and uses of psychedelic drugs. J. Alter. States Conscious 1976; 2: 133–146
   Google Scholar
• Simmons J. Q., Leiken S. J., Lovaas O. T., Schaeffer B., Perloff B. Modification of autistic behavior with LSD-25. Am. J. Psychiatry 1966; 122: 1201–1211
   PubMed Web of Science ®Google Scholar
• Sjoberg B. M., Jr., Hollister L. E. The effects of psychotomimetic drugs on primary suggestibility. Psychopharmacologia 1965; 8: 251–262
   PubMed Web of Science ®Google Scholar
• Smart R. G., Storm T., Baker E. F.W., Solursh L. Lysergic Acid Diethylamide (LSD) in the Treatment of Alcoholism. University of Toronto Press, Toronto 1967
   Google Scholar
• Smith C. M. A new adjunct to the treatment of alcoholism: The hallucinogenic drugs. Q. J. Stud. Alcohol 1958; 19: 406–407
   PubMedGoogle Scholar
• Standridge R. T., Howell H. G., Gylys J. A., Partyka R. A. Phenylalkylamines with potential psychotherapeutic utility. J. Med. Chem. 1976; 19: 1400–1404
   PubMed Web of Science ®Google Scholar
• Stoff D. M., Mandell I. J., Gorelick D. A., Bridger W. H. Acute and chronic effects of LSD and 3,4-dimethoxyphenylethylamine on shuttle-box escape/avoidance in rats. Psychopharmacologia 1974; 36: 301–312
   PubMedGoogle Scholar
• Treffert D. A. Epidemiology of infantile autism. Arch. Gen. Psychiatry 1970; 22: 431–438
   PubMed Web of Science ®Google Scholar
• Unger S. M. LSD and psychotherapy: A bibliography of the English-langauge literature. LSD–The Consciousness-Expanding Drug., D. Solomon. Putnam, New York 1964
   Google Scholar
• Unger S. The psychedelic use of LSD: Reflections and observations. Psychedelic Drugs., R. E. Hicks. Grune & Stratton, New York 1969
   Google Scholar
• Van Dusen W., Wilson W., Miners W., Hook H. Treatment of alcoholism with lysergide. Q. J. Stud. Alcohol 1967; 28: 295–304
   PubMedGoogle Scholar